Respiree secures additional funding in a Series A extension led by We Venture Capital and ClavystBio to enhance its global commercial efforts.
Round Type
Series A
HoustonInformation TechnologyBiotechnologyHealth CareArtificial IntelligenceMachine LearningInvestors
Description
Respiree, a health tech company, has expanded its Series A funding round to support growth. The round is led by We Venture Capital and ClavystBio, with participation from several other investors. The funds will be used to grow its commercial team and expand in the U.S. market
Quick answer
Respiree raised an undisclosed amount in a Series A round, dated September 22, 2026. Investors: ClavystBio, Arkray & Partners Pte. Ltd., Bizedge Capital, Adaptive Capital Partners, Greenwillow Capital Management, Seeds Capital, One Six 8 Ventures and We Venture Capital. Respiree is based in Houston, Texas, United States.
- How much did Respiree raise?
- Respiree raised an undisclosed amount in a Series A round on September 22, 2026.
- Who invested in Respiree?
- ClavystBio, Arkray & Partners Pte. Ltd., Bizedge Capital, Adaptive Capital Partners, Greenwillow Capital Management, Seeds Capital, One Six 8 Ventures and We Venture Capital are named as investors in this round.
- What does Respiree do?
- Respiree™ is an AI/ML health tech company building state-of-the-art clinically-validated artificial intelligence (AI) for managing disease progression across healthcare’s care continuum.
- Where is Respiree based and how big is it?
- Respiree is based in Houston, Texas, United States. Fundz records about 26 employees.
- Who are the decision-makers at Respiree?
- Fundz holds 4 contacts at Respiree, including the Senior Vice President (SVP), Business Development & Strategy. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Respiree that raised within 45 days of this round, from Fundz verified event records.
- Laza Medical raised $160M (Series B) on November 4, 2026.
- Pathos AI raised $237M (Series E) on October 23, 2026.
- Scarlet raised $50M (Series B) on October 12, 2026.
- Rivercell raised $25M (Seed) on October 7, 2026.
- AIBORN Ltd raised an undisclosed amount on October 5, 2026.
- UltraSight raised $24M (Series B) on September 23, 2026.
Who to call at Respiree, and when
A new round usually means Respiree is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Respiree raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Respiree, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Respiree. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Respiree raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansRespiree raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.